Bay Colony Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,691
Closed -$240K 389
2021
Q3
$240K Sell
1,691
-696
-29% -$102K 0.08% 298
2021
Q2
$373K Buy
2,387
+609
+34% +$98.6K 0.12% 209
2021
Q1
$276K Sell
1,778
-959
-35% -$149K 0.11% 244
2020
Q4
$409K Hold
2,737
0.22% 141
2020
Q3
$362K Buy
2,737
+356
+15% +$46.5K 0.22% 136
2020
Q2
$276K Sell
2,381
-284
-11% -$32.7K 0.2% 146
2020
Q1
$261K Buy
2,665
+772
+41% +$101K 0.24% 126
2019
Q4
$278K Buy
1,893
+8
+0.4% +$1.1K 0.18% 187
2019
Q3
$251K Buy
+1,885
New +$243K 0.17% 200
2019
Q1
Sell
-2,786
Closed -$281K 225
2018
Q4
$281K Sell
2,786
-48
-2% -$5.4K 0.24% 109
2018
Q3
$362K Buy
2,834
+2,756
+3,533% +$328K 0.28% 107
2018
Q2
$8K Buy
+78
New +$8.49K 0.01% 698

Other funds holding ZBH

Bay Colony Advisors's ZBH Position: Q4 2021 in Review

Bay Colony Advisors sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 1,691 shares — an estimated $240K sold.

Bay Colony Advisors first reported a position in ZBH in Q2 2018 and held it in 12 quarters. The position peaked at $409K in Q4 2020. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

  • Bay Colony Advisors reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
  • Bay Colony Advisors sold 1,691 Zimmer Biomet shares in Q4 2021, an estimated $240K.
  • Bay Colony Advisors first reported a position in Zimmer Biomet in Q2 2018 and held it in 12 quarters.
  • Bay Colony Advisors's Zimmer Biomet position peaked at $409K in Q4 2020.
  • 998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Bay Colony Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.